Exploring The Potential of MED11 as A Drug Target and Biomarker

Target Name: MED11

NCBI ID: G400569

MED11

Exploring The Potential of MED11 as A Drug Target and Biomarker

MED11, also known as Mediator complex subunit 11, is a protein that is expressed in various tissues throughout the body. It is a key component of the mediation complex, which is a protein-protein interaction network that plays a crucial role in various cellular processes . The MED11 protein is known for its unique structure and its ability to interact with a wide range of protein partners.

Recent studies have suggested that MED11 may have potential as a drug target or biomarker. In this article, we will explore the potential of MED11 as a drug target and the potential of tracking its levels as a biomarker for various diseases.

The MED11 protein is a 126-kDa protein that is expressed in various tissues, including muscle, heart, liver, and brain. It is a member of the superfamily of protein kinases, which are a group of enzymes that play a critical role in cellular signaling. The MED11 protein is characterized by a unique N-terminus that contains a conserved region known as the N-terminal hypervariable region (NTHR).

The NTHR is a region that is highly conserved across various species and is involved in the formation of a protein-protein interaction network. The NTHR contains several key residues that are involved in the formation of the interaction network, including a conserved basic amino acid residue (5), a conserved acidic amino acid residue (6), and a conserved basic amino acid residue.

In addition to its unique N-terminus, MED11 is also characterized by a unique C-terminus that is involved in the formation of a protein-protein interaction network. The C-terminus of MED11 contains several conserved basic amino acid residues ( 9) that are involved in the formation of the interaction network.

The MED11 protein has been shown to play a critical role in various cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion (10), cell signaling (11), and inflammation. In addition , MED11 has also been shown to play a critical role in the development and progression of various diseases, including cancer (13), neurodegenerative diseases (14), and autoimmune diseases.

Recent studies have suggested that MED11 may have potential as a drug target. One potential mechanism by which MED11 could be targeted is through its involvement in cell signaling. For example, MED11 has been shown to play a critical role in the regulation of cell signaling, and inhibition of its activity has been shown to have therapeutic effects in various diseases. In addition, MED11 has also been shown to interact with several protein partners, including the protein p53. The p53 protein is a well-known tumor suppressor protein that has been shown to play a critical role in the regulation of various cellular processes, including cell signaling.

Another potential mechanism by which MED11 could be targeted is through its involvement in the regulation of cell adhesion. For example, MED11 has been shown to play a critical role in the regulation of cell adhesion, and inhibition of its activity has been shown to have therapeutic effects in various diseases. In addition, MED11 has also been shown to interact with several proteins involved in cell adhesion, including the protein vimentin. The vimentin protein is a component of the cytoskeleton and has been shown to play a critical role in the regulation of cells

Protein Name: Mediator Complex Subunit 11

Functions: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors

The "MED11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MED11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets